San Diego, CA, United States of America

Suzanne Rohrback

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Suzanne Rohrback in Preeclampsia Detection**

Introduction

Suzanne Rohrback, an accomplished inventor based in San Diego, California, has made significant strides in the field of maternal health. With a focus on preeclampsia, her work aims to transform the detection and management of this serious pregnancy condition. Her innovative thinking and research have culminated in the development of a patented method that enhances the ability to identify and assess the risk of preeclampsia.

Latest Patents

Suzanne holds a notable patent titled "Circulating RNA signatures specific to preeclampsia." This invention includes methods and materials that facilitate the detection of preeclampsia and help determine the increased risk of this condition in pregnant women. The patented method involves identifying a variety of circulating RNA (C-RNA) molecules obtained from biosamples of pregnant females, showcasing a novel approach to this critical area of healthcare.

Career Highlights

Suzanne Rohrback's career has been marked by a commitment to advancing medical research and improving patient outcomes. Her affiliation with Illumina Corporation, a leader in genomics and biotechnology, has provided her with the platform to develop innovative solutions in the diagnostics field. Her efforts contribute to the ongoing evolution of targeted healthcare strategies that prioritize early detection and intervention.

Collaborations

Collaboration has played a vital role in Suzanne's success as an inventor. Noteworthy colleagues, such as Sarah E. Shultzaberger and Fiona Kaper, have worked alongside her to further refine and implement her research on preeclampsia. Together, they foster an environment of innovation, combining expertise in various scientific domains to address complex challenges in maternal health.

Conclusion

Suzanne Rohrback exemplifies the spirit of innovation within the realm of medical technology. Her dedication to developing methods that enhance the detection of preeclampsia reflects a proactive approach to maternal health. As her invention continues to garner attention, it stands as a testament to the impact that informed and inventive minds can have on the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…